Dataset Information

First clinical application of radiofrequency identification (RFID) marking system-Precise localization of a small lung nodule.

ABSTRACT:

Objectives

Precise small lung nodule resection is challenging in minimally invasive thoracoscopic surgery. Various methods that help surgeons to locate the target nodule have been devised; however, the ideal way that satisfies the demand has not yet been realized. We have developed and applied a novel marking system to localize small lung nodules for the first time in humans.

Methods

A radiofrequency identification tag (1.8 mm in diameter and 7 mm in length) that can communicate with a wand-shaped antenna (10 mm in diameter) from the distance of 3 cm was prepared. The tag was delivered adjacent to a 7-mm subsolid nodule in the right lower lobe of a patient under cone beam computed tomography guidance and video-assisted thoracoscopic surgery wedge resection was subsequently performed.

Results

The delivery of the tag was smooth, and the tag was almost immediately detected by the antenna. Wedge resection was successfully performed with the guiding signal from the tag.

Conclusions

We have so far demonstrated that this technology could be applicable for small lung nodule detection in preclinical studies. In this first clinical experience, this system proved to provide accurate positional information of small lung nodules with depth.

SUBMITTER: Sato T

PROVIDER: S-EPMC8306984 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

First clinical application of radiofrequency identification (RFID) marking system-Precise localization of a small lung nodule.

Sato Toshihiko T Yutaka Yojiro Y Nakamura Tatsuo T Date Hiroshi H

JTCVS techniques 20200924

<h4>Objectives</h4>Precise small lung nodule resection is challenging in minimally invasive thoracoscopic surgery. Various methods that help surgeons to locate the target nodule have been devised; however, the ideal way that satisfies the demand has not yet been realized. We have developed and applied a novel marking system to localize small lung nodules for the first time in humans.<h4>Methods</h4>A radiofrequency identification tag (1.8 mm in diameter and 7 mm in length) that can communicate w ...[more]

PMID: 34318053

Similar Datasets

Project description:BackgroundBreast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Approximately 50% of breast cancers are discovered at an early stage in patients for whom conservative surgery is indicated. Intraoperative localization of non-palpable breast lesions is generally accomplished using a hook wire to mark the area of concern under ultrasound or stereotactic localization. But this technique has several drawbacks (painful, stressful…). We propose the use of a wire-free breast lesion system using miniature radiofrequency identification (RFID) tags. This technique could improve patient comfort and surgical comfort for surgeons. We therefore propose a study to assess the interest of introducing the RFID localization technique at the Jean PERRIN comprehensive cancer center.MethodsThis is a single-center prospective trial designed to assess the interest in introducing the RFID localization technique at the Jean Perrin center. It aims to show the superiority of the RFID technique in terms of patient tolerance compared to the gold-standard (hook wire). A sequential inclusion in time will be performed: 20 inclusions in the gold-standard group, then 20 patients in the RFID group before repeating the inclusion scheme. Any patient requiring preoperative localization will receive a senology consultation. The RFID tag will be placed during this consultation. The hook wire localization will be done the day before the surgery. Patients will fill out a Hospital Anxiety and Depression scale (HAD) questionnaire at the time of inclusion. They will then fill out a satisfaction questionnaire in 2 steps: during the placement of the device (RFID tag or hook wire) or during the postoperative consultation at 1 month. Radiologists and surgeons will fill out a questionnaire to evaluate the localization technique, respectively after the localization and surgery procedures.DiscussionThe RFID study is the first study in France which specifically assesses the interest of the RFID localization in terms of patients comfort. Patient comfort is one of the key elements to take into consideration when managing patients in oncology and new technologies such as RFID tags could improve it.Trial registrationClinicalTrials.gov ID; NCT04750889 registered on February 11, 2021.

Project description:BackgroundMost breast cancers are detected at an early stage in which case conservative surgery is indicated. An accurate preoperative localization technique is essential for conservative surgery of non-palpable breast lesions. Currently, the gold standard technique is wire localization (WL). However, this technique has well-known drawbacks. Several wire-free techniques have been developed to overcome these drawbacks; one technique is localisation by Radiofrequency Identification (RFID). The purpose of this clinical trial was to assess the superiority of RFID tags (HOLOGIC) in terms of patient satisfaction, over wire localization of non-palpable breast lesions.MethodsThis was a single-centre, prospective, controlled and non-interventional trial. Patients were followed from their inclusion at the time of the preoperative consultation to the postoperative consultation, one month after surgery. Data on anxiety and satisfaction was collected from patients and clinicians using questionnaires, and clinical data was collected from the medical files. The primary outcome was the patients' satisfaction scores, assessed using a visual analogue scale.ResultsEighty patients were sequentially enrolled in two groups: the wire group (n = 40) and the RFID group (n = 40). One patient from the RFID group was excluded from the analysis because of a substantial migration during deployment. On a 10-point Visual Analogue Scale, the patients' median satisfaction score was 9.8 (IQR = 1.32) for the wire group and 10 (IQR = 0.07) for the RFID group (p < 0.001). A reduction in pain between device insertion and surgery was observed in the RFID group (p = 0.009). The median placement time was shorter in the RFID group (15 min, IQR = 6) than in the wire group (20 min, IQR = 30) (p = 0.01).ConclusionOur results show a statistically significant difference in median patient satisfaction score with the localization of non-palpable breast cancer lesions using RFID tags compared to the use of the WL. Although our results did not show clinically significant outcomes in terms of satisfaction, RFID tags are a reliable alternative to WL and simplify the organization of patients' healthcare trajectories.Trial registrationClinicalTrials.gov ID; NCT04750889 registered on February 11, 2021. https://clinicaltrials.gov/ct2/show/NCT04750889?term=rfid&draw=2&rank=1.

Project description:BackgroundIn the process of video-assisted thoracoscopic surgery (VATS) for lung nodule resection, lung is leaded to atelectasis. However, preoperative computed tomography (CT) images are taken during inspiration, which means they differ significantly from the lung status observed during surgery. Consequently, this discrepancy can make the localization of small or subsolid nodules challenging during the operation. This study aimed to develop a CT-based virtual atelectasis simulation system for noninvasive lung nodule localization. By accurately simulating atelectasis, this study aimed to improve the precision of presurgical planning from lung nodule resections.MethodsThis study retrospectively examined 20 patients who had either subsolid nodules or small nodules less than 3 cm in size, selected from a cohort of 279 patients who underwent VATS surgery for lung nodules in Korea University Ansan Hospital between June 28, 2021, and January 22, 2024. Chest CT images of the lungs of 20 patients were acquired, and image data were converted three-dimensional models. The mesh points extracted from these lung models were manipulated to simulate the effects of gravity, by adjusting the lung shapes and nodule locations to align with the respective surgical postures of the patients. Subsequently, we assessed the similarity of the simulation by comparing the resulting deformed lung shapes and nodule locations with the corresponding perspectives observed in the surgical videos.ResultsThe average volume of the entire lung among the patients was 2,336 cm3 (±588). After atelectasis simulation, the average lung shrinkage rate was 48.6% (±12.9%). Evaluations of an average of 15 pairs of images per case revealed significant conformity between atelectasis simulation images and surgical video snapshots, with average Dice and Jaccard similarity coefficient values of 90.27 and 88.25, respectively. Furthermore, the alignment of nodule locations between the simulations and surgical anticipation demonstrated notable accuracy, with an average Hausdorff distance of 6.39 mm.ConclusionsWe successfully developed a simulation of lung atelectasis based on preoperative CT scans that closely resembled actual surgical videos. The integration of this presurgical atelectasis simulation is anticipated to enhance the accuracy of nodule locations, thus contributing to more efficient and precise surgical planning.

Project description:BackgroundThe use of two-dimensional (2D) ultrasound for guiding radiofrequency ablation (RFA) of benign thyroid nodules presents limitations, including the inability to monitor the entire treatment volume and operator dependency in electrode positioning. We compared three-dimensional (3D)-guided RFA using a matrix ultrasound transducer with conventional 2D-ultrasound guidance in an anthropomorphic thyroid nodule phantom incorporated additionally with temperature-sensitive albumin.MethodsTwenty-four phantoms with 48 nodules were constructed and ablated by an experienced radiologist using either 2D- or 3D-ultrasound guidance. Postablation T2-weighted magnetic resonance imaging scans were acquired to determine the final ablation temperature distribution in the phantoms. These were used to analyze ablation parameters, such as the nodule ablation percentage. Further, additional procedure parameters, such as dominant/non-dominant hand use, were recorded.ResultsNonsignificant trends towards lower ablated volumes for both within (74.4 ± 9.1% (median ± interquartile range) versus 78.8 ± 11.8%) and outside of the nodule (0.35 ± 0.18 mL versus 0.45 ± 0.46 mL), along with lower variances in performance, were noted for the 3D-guided ablation. For the total ablation percentage, 2D-guided dominant hand ablation performed better than 2D-guided non-dominant hand ablation (81.0% versus 73.2%, p = 0.045), while there was no significant effect in the hand comparison for 3D-guided ablation.Conclusion3D-ultrasound-guided RFA showed no significantly different results compared to 2D guidance, while 3D ultrasound showed a reduced variance in RFA. A significant reduction in operator-ablating hand dependence was observed when using 3D guidance. Further research into the use of 3D ultrasound for RFA is warranted.Relevance statementUsing 3D ultrasound for thyroid nodule RFA could improve the clinical outcome. A platform that creates 3D data could be used for thyroid diagnosis, therapy planning, and navigational tools.Key pointsTwenty-four in-house-developed thyroid nodule phantoms with 48 nodules were constructed. RFA was performed under 2D- or 3D-ultrasound guidance. 3D- and 2D ultrasound-guided RFAs showed comparable performance. Real-time dual-plane imaging may offer an improved overview of the ablation zone and aid electrode positioning. Dominant and non-dominant hand 3D-ultrasound-guided RFA outcomes were comparable.

Dataset Information

First clinical application of radiofrequency identification (RFID) marking system-Precise localization of a small lung nodule.

Objectives

Methods

Results

Conclusions

Publications

First clinical application of radiofrequency identification (RFID) marking system-Precise localization of a small lung nodule.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets